Clinical trials: Abortion, Drug-Induced
Misoprostol, Drug-induced Abortion
Compare the Different Routes of Administration of Misoprostol During Medicinal Abortion Between 7 and 9 Weeks of Amenorrhoea (SA)
In France, drug-induced abortion is allowed up to 9SA, after which the surgical route is preferred. Mifepristone 600mg is used 36-48 hours before the introduction of Misoprostol. This is recommended orally at a dose of 400 μg.
- Trial name
- Misoprostol (NCT03140384)
- Testing
- Assess the efficacy and side effects of Misoprostol according to the route of administration
- Where
- France
- Sponsor
- Centre Hospitalier Universitaire, Amiens
Abortion; Induced
Same-day Long-acting Reversible Contraception for Medication Abortion
Contraception after abortion is an important public health issue, as women who have an abortion are at high risk for additional unintended pregnancy.
- Trial name
- SaLMA (NCT01356927)
- Testing
- DMPA, Etonogestrel implant
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Boston University
Pain
Pain and Medical Abortion Among Teenaged Women Compared to Adult Women
In this two-parted study the need and sufficiency of analgesics and experienced pain is compared between teen-aged and adult women undergoing medical termination of pregnancy (MToP)in early pregnancy (under 9weeks of gestation).
- Trial name
- NCT02678897
- Testing
- Oxynorm on-demand, Oxynorm via PCA
- Where
- 2 sites in Finland
- Volunteers
- 242 people
- Sponsor
- Helsinki University Central Hospital
Induced Abortion, First Trimester Abortion
Study of Clinic-based vs. Self-use of a Misoprostol-only Regimen for Induced Abortion
The goal of the study is to determine whether important clinical outcomes differ among women who access a misoprostol-only medication abortion regimen from a patent medicine vendor when compared with those who access it from a…
- Trial name
- NCT04242212
- Testing
- Misoprostol sourced from clinics, Misoprostol sourced from PMVs
- Where
- 3 sites in Nigeria
- Volunteers
- 4,000 people, healthy volunteers welcome
- Sponsor
- Ipas
Abortion, Complete, Fetal Death
IntraCERvical Balloon Catheter in the Setting of Induction of Labor for Fetal Loss or Abortion
The goal of this research is to understand whether it is practical and safe to use an intracervical balloon catheter in addition to standard of care medications at the time of an induction of labor for an abortion or fetal death.
- Conditions
- Abortion, Complete, Fetal Death, Induction of Labor Affected Fetus / Newborn
- Trial name
- CERBI (NCT06456164)
- Testing
- Cook Cervical Ripening Balloon
- Sponsor
- University of Chicago
Abortion, Drug-Induced, Pharmacies
Evaluating an Intervention to Increase Use of Call Centre Support for Self-managed Medical Abortion
Self-management of medical abortion (MA) pills purchased from pharmacies is considered to be one of the reasons behind falling morbidity and mortality from unsafe abortion in recent years.
- Trial name
- NCT03248050
- Testing
- Pharmacy encouraged to promote call centre use to clients
- Volunteers
- 1,359 people, healthy volunteers welcome
- Sponsor
- Marie Stopes International
Abortion, Induced, Labor Stage, Third/Drug Effects
Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion
This study compares oxytocin infusion to spontaneous follow-up for third-stage of labor at induced mid-trimester abortions. Patients will be randomized to oxytocin infusion or observation with no pharmacologic intervention.
- Conditions
- Abortion, Induced, Labor Stage, Third/Drug Effects, Pregnancy Trimester, Second, Oxytocin/Administration & Dosage
- Trial name
- NCT02485444
- Testing
- Oxytocin
- Where
- Turkey (Türkiye)
- Volunteers
- 160 people
- Sponsor
- Ataturk University